Commercial Readiness Diagnostic (CRD)
Decision-grade clarity for high-stakes commercial decisions.
A fixed-scope, executive-level diagnostic designed for moments where being wrong is expensive. The CRD helps medical device leaders understand what is actually blocking commercial progress and decide, with confidence, what to do next—before scaling, partnering, or raising.
Most commercial mistakes aren't obvious—until they're expensive.
Medical device companies rarely fail because the technology doesn't work. They stall or destroy value because commercial decisions are made out of sequence, without a defensible assessment of readiness.
- Launching before buyer clarity exists
- Hiring sales before positioning or evidence is aligned
- Fundraising with a story that doesn't match go-to-market reality
- Chasing pilots or partners without repeatable commercial logic
- Internal disagreement disguised as "we're still figuring it out"
The CRD surfaces these issues early—while they're still fixable.
A decision-forcing commercial diagnostic—not an execution engagement.
The Commercial Readiness Diagnostic is a 2–3 week, fixed-scope, executive-level assessment designed to determine whether a medical device company is truly ready to commercialize, partner, or scale.
This is not a workshop or brainstorming exercise.
It is structured judgment at the moment it matters.
How the CRD works
Step 01
Pre-Engagement Intake
A short intake to confirm fit, stage, and decision context.
Step 02
Executive Interview(s)
Structured interviews with decision-makers to surface assumptions, blockers, and misalignment.
Step 03
Internal Synthesis & Scoring
Judgment-driven synthesis to score readiness, rank blockers, identify risks, and define the roadmap.
Step 04
CRD Report Generation
Findings are converted into an executive-ready report designed to support decision-making.
Step 05
Executive Readout
A focused decision meeting. The report supports the conversation—the decision is the outcome.
What you walk away with
Executive Summary
(Board-Ready)
A concise, skeptical summary of readiness, blockers, risks, and priorities—built to support executive and board-level decisions.
Commercial Readiness Scorecard
A structured assessment across six dimensions: Clarity of Offering, Market Fit Realism, Differentiation & Positioning, Evidence & Credibility, Commercial Readiness (go-to-market Mechanics), Execution Infrastructure
Ranked Commercial Blockers
The top 3–5 issues that will prevent progress even if everything else goes right—ranked by commercial impact.
Risk Register
Forward-looking risks that could derail commercialization if not actively managed.
90-Day Commercial Readiness Roadmap
A sequenced view of what to do first, what to do next, what to delay, and what to stop—based on readiness, not ambition.
Executive Readout
A decision-oriented readout designed to align leadership and force a clear next step.
Who the CRD is for
Best fit:
- Medical device companies (Class II / III or similarly complex, regulated products)
- Pre-launch, early commercial, or stalled traction
- Facing a major decision: scale, hire, partner, or raise
- Willing to invest in clarity before committing resources
Not a fit:
- Pre-concept or exploratory teams
- Companies seeking outsourced marketing or lead generation
- Teams unwilling to confront uncomfortable constraints
What the CRD is not
To be explicit, the CRD is not:
- Marketing execution
- Sales outsourcing
- Regulatory consulting
- Coaching or brainstorming
- A validation exercise
If the honest conclusion is that you're not ready,
we will say so.
What comes after
Some teams use the CRD purely for clarity and alignment.
Others engage us to help execute what the diagnostic surfaces.
Execution is optional. The CRD stands on its own.